Who We Are

Our Vision

The cost of healthcare is out of control. To put it lightly.

Too many unneeded tests. Or, worse yet, too many missed tests—costing us all down the road.

Scientific advancements are accelerating, and the world of genetics is exploding.

It’s getting harder to keep up, let alone keep people healthy.

At Avalon, we are pioneering a new era of value-driven care by unlocking the potential of lab values to proactively drive appropriate care and enhance clinical outcomes.

We have developed the world’s first Lab Insights System to help our customers enable value-driven care in this dynamic and increasingly challenging environment.

By generating actionable lab-driven insights in real time at scale, we help our customers accelerate results and unleash new opportunities to achieve the Triple Aim.

Avalon’s access to lab data, combined with the comprehensive lab benefit management experience and leadership in lab sciences, provides a powerful platform for analytics and the realization of patient-centered, value-based care—right from the start with lab testing.

It’s time to start thinking differently about lab.

Our Values

  • We seek to understand and deliver sound science
  • We are committed to enhancing the quality of care
  • We hold ourselves to a higher standard
  • We are resourceful and action oriented
  • We look to continuously improve everything we do
  • We celebrate our successes, large and small

Our Leadership

Executive Team
Bill Kerr Headshot
Bill Kerr, M.D.

Chief Executive Officer

Rahul Headshot
Rahul Singal, M.D.

Chief Medical Officer

SHANTHA headshot
Shantha Diaz

Chief Operating Officer

Kerri Headshot
Kerri Fritsch

Chief Client Officer

Wendy Headshot
Wendy Mudra

VP of Human Resources

Rhonda headshot
Rhonda Willingham

Senior VP of Product & Marketing

Barry Davis Headshot
Barry Davis

Chief Growth Officer

Steve headshot
Steve Morgan

General Counsel

John Headshot
John Adams

Chief Financial Officer

Jason Headshot
Jason Bush, Ph.D.

Chief Data Officer

Mike Headshot
Mike Snyder

Executive VP of Provider Networks

Clinical Advisory Board

Our independent Clinical Advisory Board (CAB) is comprised of experts with well-renowned expertise in their fields of hematology, laboratory science, molecular genetics, and pathology. They bring practical insights, front-line laboratory experience, and real-world use cases to their review and approval of our 140 lab policies which support the goal of delivering value-driven care.

Our Recognition

We’re proud of what we do. We’re awarded for how we do it.


Ready to help pioneer a new era in value-driven care by unlocking the potential of lab values to proactively drive appropriate care and enhance clinical outcomes?

We’re looking for people who are:

  • Passionate about improving quality, access, and affordability of healthcare for millions of people
  • Excited to join a team that succeeds by delivering extraordinary care to our customers
  • Committed to upholding science as a guiding principle
  • Looking for an inclusive and respectful environment that values individual contributions
Join the Avalon Team

Our Governance

Compliance and Integrity

Avalon implemented a comprehensive compliance program that is integrated throughout the organization. Avalon’s General Counsel is the Chief Compliance Officer and is supported by Avalon’s Board of Directors, Compliance Committee, Privacy Officer, and Security Officer.

Avalon is committed to a culture of compliance and supports its employees, vendors, contractors, clients, providers, and customers in reporting suspected violations of compliance, fraud, waste, and abuse, or complaints about Avalon’s Privacy and Security policies without fear of retaliation.

Privacy and Security

Avalon is a technology-enabled laboratory benefit manager that utilizes state-of-the-art technology to protect the privacy and security of its data. Any concerns or complaints regarding Avalon’s privacy or security policies may be directed to Avalon’s Privacy or Security Officer by calling toll free 1-855-751-5048, or visiting www.avalonhcs.ethicspoint.com

Requests for access, amendments, or restrictions to PHI, or an accounting of disclosures must be made in writing to:

Privacy Officer

3405 W Dr. Martin Luther King Jr. Blvd., Suite 200 Tampa, FL 33607

Reporting Healthcare Fraud, Waste, and Abuse

Healthcare fraud affects all of us in many ways. The National Heathcare Anti-Fraud Association estimates conservatively that healthcare fraud costs the nation about $68 billion annually—about 3 percent of the nation’s $2.26 trillion in healthcare spending. If you have a concern, you may make a report, anonymously if preferred, by calling toll free 1-855-751-5048, or visiting www.avalonhcs.ethicspoint.com

Connect With Us

Want to get in touch? We’d love to hear from you.

Bill Kerr, M.D.


Good clinical decision-making requires ordering the right test at the right time from the right provider. With the science of laboratory testing exploding, Dr. Kerr is pleased to be a part of the Avalon team’s ability to scale laboratory science into the healthcare ecosystem.

Before cofounding Avalon, Dr. Kerr was the Chief Medical and Growth Officer at CareCentrix, a company focused on health in the home. Prior to CareCentrix, Dr. Kerr was the Chief Medical Officer at WellCare Health Plans and Blue Cross Blue Shield of Florida. Dr. Kerr was previously Vice President of Professional Networks at Independence Blue Cross and regional medical director for a number of plans in Texas.

Dr. Kerr holds a BA from the University of Arkansas, an MBA from the University of Houston, an MD from the University of Arkansas. He was also a research associate in the Nuffield department of pathology at the University of Oxford.

Rahul Singal, M.D.


Dr. Singal joined Avalon Healthcare Solutions as its Chief Medical Officer in 2021. Dr. Singal has 20+ years of healthcare experience as a scientist, practicing internist, health plan medical director and healthcare information technology entrepreneur.

Prior to joining Avalon, Dr. Singal was CMO of ZeOmega, a population health management (PHM) and advanced analytics platform company. From 2013 to 2015, he was Chief Medical Officer of DST Health where he led product innovation and clinical oversight for the company’s two healthcare divisions.

Dr. Singal earned his undergraduate degree at University of Southern California, medical degree at Stanford Medical School and completed his residency in Internal Medicine at the Washington University School of Medicine. During his years at Stanford, he also conducted 3 years of molecular biology research in an HIV vaccine laboratory where he learned the value of questioning the status quo and dogma based upon superficial analysis.

Shantha Diaz


In her role as Avalon Healthcare Solutions’ Chief Operating Officer, Shantha Diaz leads the Information Technology, Claims & Clinical Operations, Policy Development, Quality, Clinical Configuration, Client Implementation, and Corporate Development activities.

Prior to joining Avalon in 2017, Shantha was Chief Operating Officer of Neighborhood Health Plan of Rhode Island. In that capacity, she helped implement ACA, launched three new product lines, doubled the plan’s membership, and contributed to increasing the company’s revenue to $1.1 Billion dollars.

Shantha previously served as Staff VP of Medical Business Solutions at Anthem Blue Cross Blue Shield. She also spent several years in information technology roles at Humana, International Data Group, and Toyota.

Shantha holds a BS in Finance and Accounting from the University of Bombay and a PG in Computer Applications from India’s National Institute of Information Technology.

Kerri Fritsch


Kerri Fritsch is Avalon Healthcare Solutions’ Chief Client Officer. She leads the Client Management department with a focus on exceeding client expectations and enhancing client value. Kerri has also fostered effective relationships with Avalon’s client base and values collaborative partnerships.

Prior to joining Avalon in 2015, Kerri held leadership positions in client management, operations, and financial management. She was VP of Client Services at New Century Health and VP of Product Development at CareCentrix, where she helped develop and launch a successful hospital readmission reduction program. Kerri’s other health plan roles have included VP of Finance for WellCare’s health services division and AVP of Performance Management for AmeriGroup FL.

Kerri also served as CEO of physician practice management company CoreManagement, which specialized in billing and operational solutions for primary care and specialty practices.

Kerri holds a BS in Finance from Providence College, where she was a division I scholarship athlete for tennis. She received her MBA/MHA from Pfeiffer University.

Wendy Mudra


Wendy Mudra is Vice President of Human Resources at Avalon Healthcare Solutions. In addition to being responsible for all tactical HR requirements at the company, she also plays a strategic role in staffing, organizational development, and creating a vibrant organizational culture.

Prior to joining Avalon in 2015 as its first Human Resources employee, Wendy had 20 years of experience in the HR field, primarily with small to midsize companies. She was the Director of Human Resources at start-up specialty property and casualty insurance company Mount Beacon Insurance Company. She also held management positions at HCI and IFCO Systems. Early in her career, Wendy obtained generalist experience at Airem Capital and Uniroyal Optoelectronics.

Wendy holds a BA in Political Science from Wittenberg University. She is also PHR-certified through the Society for Human Resources Management.

Rhonda Willingham


Rhonda Willingham is Senior Vice President of Product and Marketing at Avalon Healthcare Solutions, where she is responsible for driving the company’s product roadmap development and marketing strategies.

Prior to joining Avalon in 2020, Rhonda has more than 25 years of experience partnering with health plans across all lines of business with a focus on driving operational, financial, and clinical value-driven results. Rhonda also successfully led growth strategies and teams at healthcare technology organizations including New Century Health, Medecision, VRI, and Alere.

Rhonda holds a BS in nursing from the University of Florida.

Barry Davis


In his role as Chief Growth Officer at Avalon Healthcare Solutions, Barry Davis is responsible for growing the company’s revenues and services through a national business development strategy.

Barry possesses 30 years of healthcare experience working with and servicing health plans. Prior to joining Avalon in 2017, he was Sr. Vice President of the Health Plan Segment at OptumRx, the Pharmacy Benefit Management division of UnitedHealth Group. In that capacity, Barry led a cross-functional team managing a multi-billion dollar business.

Barry is a former member of the executive team for Chicago’s CatamaranRx. He also spent nearly 20 years in various sales, service, and operations roles at Medco Health Solutions (now part of Express Scripts).

Barry holds a BSBA from Bucknell University.

Steve Morgan


Steve Morgan is General Counsel at Avalon Healthcare Solutions. An attorney with extensive healthcare regulatory, transactional, and management experience, Steve is responsible for all legal, compliance, and government affairs matters pertaining to the company.

Prior to joining Avalon in 2015, Steve spent a decade with the nation’s largest pharmacy benefit manager, Express Scripts. Serving as Vice President and Associate General Counsel, Steve managed a team of attorneys and compliance officers supporting numerous Express Scripts businesses, including its PBM, government programs, Accredo Specialty Pharmacy, United BioSource Corporation, Freedom Fertility Pharmacy, and CuraScript SD Specialty Distribution. During Steve’s tenure at Express Scripts, the company grew from $16 billion to more than $100 billion in annual revenue. This growth was fueled in part by numerous acquisitions for which Steve provided legal support, including Express Scripts’ $29 billion acquisition of Medco Health Solutions.

Steve previously worked for two Washington, D.C. law firms, where his legal practice focused on managed care organizations, healthcare providers, and pharmaceutical manufacturers.

Steve received his BA with magna cum laude honors and a professional MBA from the University of Missouri. He received his JD with magna cum laude honors and MHA with distinction from St. Louis University.

John Adams


As Chief Financial Officer of Avalon Healthcare Solutions, John Adams is responsible for the company’s day to day financial and accounting functions. He plays a strategic role in the company’s overall management, including shaping payor contracts, customer pricing strategies, broader business model decisions, and future M&A opportunities.

Prior to joining Avalon in December of 2018, John served as CFO of California-based Medicare Advantage plan Alignment Healthcare, as well as of clinical laboratory services company Accumen. His other leadership roles have included EVP & COO at marketing services company Acxiom; EVP of Business Solutions at healthcare software company Eclipsys; and CFO of AT&T Business Services. John’s experience ranges from global, multi-billion-dollar businesses to start-up and young high-growth companies backed by private equity investors. Early in his career, John worked with EDS in various financial and operational roles for 15 years.

John has a BA in economics from the University of Exeter (UK). He is a member of the Institute of Chartered Accountants.

Jason Bush, Ph.D.


Dr. Jason Bush is Chief Data Officer at Avalon Healthcare Solutions, where he leads the data analytics infrastructure strategy supporting new product development, advanced analytics, underwriting & deal structure analysis, and reporting services.

Jason has more than 20 years of experience in venture capital-backed healthcare and life sciences companies. He joined Avalon in 2015 as the Senior Vice President of Clinical Operations and business owner for Avalon’s proprietary, best-in-class, flagship software, which automates the application of laboratory policies to health insurance claims. Prior to that, Jason served as Vice President of Operations at AIT Laboratories (now HealthTrackRX), a commercial toxicology and forensic science laboratory, where he was integral in the company’s restructuring. As former Director of Clinical Operations for Precision Therapeutics (now Helomics), Jason led the laboratory through two years of 300 percent growth.

Jason received his Ph.D. in Chemical Engineering – Bioengineering from Carnegie Mellon University and an MBA from the University of Pittsburgh.

Mike Snyder


As Executive Vice President of Provider Networks for Avalon Healthcare Solutions, Mike Snyder manages laboratory networks that support high-quality, cost-effective laboratory services while promoting appropriate testing for patients.

Mike has more than 30 years of experience in the development of clinical laboratory strategies. Prior to joining Avalon, he was the Principal for Clinical Lab Business Solutions, a consulting firm that engages with laboratories to deliver collaborative solutions to health plans and employer groups. Mike has also served as Vice President of Laboratory Networks for UnitedHealthcare (UHC). In that capacity, he directed the company’s national strategy for laboratory services and participated in the development of its national provider network.

Previously, Mike served as Director of Business Development for Mount Sinai Hospital’s Center for Clinical Laboratories, where he saw outreach revenues triple following the implementation of a business plan that focused efforts on billing solutions and demonstrated the value of the medical center’s laboratory to attending faculty. Finally, Mike served as an executive with LabCorp (1980-2000), one of the largest commercial laboratories in the US.

He received his undergraduate degree at East Carolina University before commencing post-graduate studies at the University of North Carolina.

Geoffrey S. Baird, M.D., Ph.D.


Dr. Baird is the Chair of the Avalon Clinical Advisory Board. He is board-certified in Anatomic and Clinical Pathology as well as Clinical Chemistry. Dr. Baird serves as both Interim Chair and Associate Professor of Laboratory Medicine as well as an Adjunct Associate Professor of Pathology at the University of Washington in Seattle, WA. He is the Laboratory Medical Director at Northwest Hospital and Airlift Northwest, and the Director of Clinical Chemistry at Harborview Medical Center. He was formerly the Associate Program Director of the UW Clinical Pathology Residency Program and Director of the UW Clinical Chemistry Fellowship Program.

Dr. Baird serves on numerous local and national committees, including the CMS/PAMA Clinical Diagnostic Laboratory Test Panel and ASCP’s Choosing Wisely Campaign Committee where he has been instrumental in developing the ASCP’s Choosing Wisely recommendations. He is the recipient of the AACC’s Grannis Award for Excellence in Research and Scientific Publication and the International Federation of Clinical Chemistry’s Young Investigator award.

Dr. Baird is a member of the Academy of Clinical Laboratory Physicians and Scientists. His clinical interests include rational laboratory test utilization, chemistry and toxicology, molecular diagnostics and proteomics.

Dr. Baird is a graduate of Stanford University with a BS in Chemistry. He received his MD and PhD at the University of California, San Diego, and did his residency in Anatomic and Clinical Pathology at the University of Washington in Seattle.

Timothy R. Hamill, M.D.

Dr. Timothy Hamill is the Prior Director of Clinical Laboratories at UCSF Medical Center’s China Basin and Parnassus campuses. In addition, he is Professor Emeritus and Ex-Vice Chair of the UCSF Department of Laboratory Medicine.

Dr. Hamill has held numerous memberships in UCSF Medical Center committees in his tenure, including the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also past chair of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC). He is currently President and member of the Board for the California Society of Pathologists, and a fellow of the American Society of Clinical Pathologists and College of American Pathologists.

In his career, Dr. Hamill has taken a lead in promoting laboratory science as a career and clinical laboratory scientist training as the Co-Chair of the Hospital Laboratory Workforce Initiative of the California Hospital Association. In addition, he has also been involved in developing better point-of-care testing practices through the College of American Pathologists as the Vice-Chair of the Point of Care Testing Resource Committee.

Dr. Hamill completed his medical degree from UC Davis’ School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in Hematopathology at the Veterans Administration Medical Center in Martinez, CA. He is board-certified in clinical pathology and also hematopathology.

Victoria M. Pratt, Ph.D.

Dr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.

In addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC’s GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the Institute of Medicine/National Academy of Medicine’s Roundtable on Translating Genomic-Based Research for Health and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC).

Dr. Pratt is Past Chair of the Clinical Practice Committee and is currently a member of the Professional Relations committee, and is the chair of the Program committee for the Association of Molecular Pathology. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association’s (AMA’s) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.

Dr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.

Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.

Brian P. Rubin, M.D., Ph.D.

Dr. Rubin is Professor and Vice Chair of Pathology, Director, Soft Tissue Pathology, Director, Bone & Soft Tissue Pathology Fellowship Program, Staff, Department of Cancer Biology and Practicing Pathologist with sub-specialty expertise in bone and soft tissue tumors, Cleveland Clinic.

Dr. Rubin is Staff, Department of Cancer Biology, Lerner Research Institute and Cleveland Clinic.

Clinical Interests: Bone and Soft Tissue Tumor Diagnosis and Classification, Cancer Genetics, Digital Pathology, Molecular Pathology


Brian R. Smith, M.D.

Dr. Smith is Chair of the Department of Laboratory Medicine at the Yale School of Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is also the Chief of Laboratory Medicine at Yale New Haven Hospital.

Dr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women’s Hospital, Boston Children’s Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. He practices in all of his subspecialty areas. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-coagulation interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His educational activities include direction of an NIH-funded research training program in Immunohematology and Transfusion Medicine. He also lectures in the areas of biomedical ethics, “therapeutic pathology”, and in the education of the physician-scientist. Nationally, he has been member and chair for various NIH and American Heart Association research study sections, chair of the Association of Pathology Chairs Research Committee, and a member of the CDC Clinical Laboratory Integration into Healthcare Collaborative. He is the recipient of a number of Awards including Stohlman Scholar of the Leukemia & Lymphoma Society, National Blood Foundation Scholar, the Evans Award from the Academy of Clinical Laboratory Physicians and Scientists, and has served as a visiting professor at a number of universities.

Ezra Perlman

Ezra Perlman is a Partner at Francisco Partners and focuses primarily on investments in the software and services sectors, with a specific emphasis on healthcare technology.

Prior to joining Francisco Partners in 2003, Ezra was a venture capitalist with Battery Ventures, where he was involved in identifying, executing and managing private equity investments in software companies.

Ezra serves on the board of directors of Aesynt, API Healthcare, Healthland, Quantros, T-System and Therapeutic Research. He formerly served on the board of directors of Aconex, AdvancedMD, Attachmate, Attenti, Avangate, LYNX Medical Systems, RedPrairie, and SMART Modular.

Lauren Macklis

Lauren Macklis is Vice President Network Business Development and Retail Solutions at Health Care Service Corporation (HCSC). HCSC is the largest customer owned-health insurer in the United States, operating Blue Cross Blue Shield Illinois, Montana, New Mexico, Oklahoma and Texas. Lauren oversees Value Based Care Payment Operations, Provider Partnerships, Provider Payment Innovation and Analytics, as well as Retail Solutions (Individual U65).

Prior to her current role, Lauren was Vice President Divisional Strategy and Analytics, where Lauren developed line of business strategy and investment portfolio for Government and Consumer Solutions, and led the Government Programs Business Execution teams, as well as the Individual Markets data and analytics team.

Before joining HCSC in 2011, Lauren led strategic planning and business development teams at Rush University Medical Center, a large academic medical center and health sciences university. While at Rush, Lauren implemented several initiatives for the medical center including multi-hospital telemedicine network, off-site clinics, and practice affiliations.

Lauren received a Master of Health Services Administration from the University of Michigan and a Bachelor’s degree in Community Health – Health Planning and Administration from the University of Illinois.

Stephany Verstraete

Stephany Verstraete serves as the Chief Marketing & Engagement Officer at Teladoc Health Inc., responsible for all marketing, communications and consumer visit revenue for the global leader in whole person virtual care.

A seasoned, high-growth leader who has held executive marketing roles spanning a breadth of industries in both public and private companies, Stephany has a proven record of building businesses and leading during periods of outstanding growth.

With a 20+ year record of successfully building brands and growing high-performing teams, she has held leadership roles at Match.com, Expedia, Hostess and PepsiCo. She was also a member of the founding team at a travel-based start-up.

Proficient in Spanish & French, Stephany holds an International Master of Business Administration from York University and an Honors Bachelor of Economics from Queen’s University in Canada.

Duncan James

Duncan James is an Operating Partner with Francisco Partners and focuses on the healthcare IT market.

Prior to Operating Partner role with Francisco Partners, Duncan was the CEO of two private-equity backed healthcare IT companies, MModal and QuadraMed. He also served as Group President at McKesson Corporation for 9 years responsible for the hospital and health systems market solutions and was a member of the McKesson Corporate Operating Committee. Duncan brings more than 25 years of experience in healthcare IT spanning domestic and international operations, strategic planning, sales and marketing, services, and product management.

Duncan serves on the Board of additional Francisco Partner companies including e-Solutions, Nextech, and QGenda. He received his Bachelor of Science degree in Industrial Management from the Georgia Institute of Technology.


Jessica A. Zeaske

As a Partner at Echo Health Ventures in Boston, Jessica A. Zeaske, PhD, MHS, MBA, identifies and invests in emerging and growth stage companies for Echo. She is a seasoned venture capitalist and board leader having worked at independent, corporate, and university funds, and has written dozens of investment themes over the years. She previously served as Director of Healthcare Investments at GE Ventures where she invested in precision health companies. Jessica came to GE Ventures from Lemhi Ventures, a fund investing in healthcare services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech and Life Science companies based on University intellectual property at U of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up healthcare delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven healthcare start-up companies.

Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica currently serves on the Boards of Avalon Healthcare Services, Genome Medical and Wildflower Health and is a Board Observer at Abacus Insights. Her previous Board of Director experience includes Apervita, Arcadia.io, PlanSource, OneHealth, PokitDok, Orasi Medical, Medication Management Solutions, plus significant work at Bind On-Demand Health Insurance. Jessica also serves on the Board of DentaQuest Partnership for Oral Health Advancement, is a Trustee for Boston Medical Center’s Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children’s Hospital, and is a member of the National Association of Corporate Directors.

Andy Folsom

Andy Folsom joined BlueCross BlueShield of South Carolina (BCBSSC) in Columbia, SC in 2009. He currently serves as AVP, Strategic Investments and M&A, and also as President of Companion Capital Management, Inc., a wholly owned subsidiary of BCBSSC. Prior to this role, Andy worked in the Law Department at BCBSSC as AVP and Deputy General Counsel. Before joining BCBSSC, Andy worked as a corporate transactional attorney at Alston & Bird in Atlanta, GA. Andy holds a BA from Washington and Lee University and a JD from the University of South Carolina School of Law.

In addition to his role at BCBSSC, Andy currently serves as a Board member at the Columbia Chamber of Commerce (Executive Committee member), United Way of the Midlands, Salute from the Shore (Chairman), Sisters of Charity Foundation of South Carolina (Executive Committee member), and Riverbanks Zoo Society (Executive Committee member).

Holly Benson

Holly Benson recently retired as the EVP, President and CEO of Health Care Enterprises which is a division of Centene Corporation and currently serves as a Board member and advisor for several companies. In her role at Centene, she led a portfolio of entrepreneurial acquisitions, including the country’s largest in-home primary care provider (USMM), an 18-clinic primary care group (Community Medical Group), a multi-state third party administrator (HealthSmart), a provider of services to individuals with Intellectual and Developmental Disabilities (LifeShare), an industry-leading case management software company (Casenet) and a cutting-edge health care analytics company (Interpreta). She was responsible for helping grow those companies, expanding their product offerings to internal and external customers and integrating core functions into Centene.

Holly joined Centene in March 2011 as Centene’s Senior Vice President of Health Policy. In that role, she was responsible for the development of policy positions for the company and worked with health plan and specialty company presidents to develop Centene’s policy agenda. She also worked with the business development team to craft policy solutions in new markets.

Before joining Centene, Holly served as Secretary for the Florida Agency for Health Care Administration, the state agency responsible for Florida’s Medicaid program. She also served as Secretary for the Florida Department of Business and Professional Regulation, and she served as a member of the Florida House of Representatives. During her time in the House, Ms. Benson served as Chair of the Health Care Council, of the Select Committee on Article V, and of the Committee on State Administration. Ms. Benson also spent 10 years practicing municipal bond law with Miller, Canfield, Paddock and Stone, P.L.C.

Ms. Benson graduated with honors from Dartmouth College and earned her law degree from the University of Florida College of Law. She serves on the Board of Ascension Florida and served on the Boards of the St. Louis Sports Commission, the Missouri History Museum, and LaunchCode. She also served on the Selection Committee for Arch Grants and was the founder of St. Louis Opera Theatre’s Intermezzo Society.


David H. Klein

David is a special advisor to the CEO of the University of Rochester (U of R) Medical Center, a professor of public health sciences in the U of R School of Medicine and Dentistry and an executive professor of health care management in the U of R William E. Simon Graduate School of Business (Simon School).

David was CEO of The Lifetime Healthcare Companies (TLHC) in Rochester, NY which includes Excellus BlueCross BlueShield, Univera Healthcare, Lifetime Health Medical Group, Lifetime Care, EBS-RMSCO Benefit Solutions and MedAmerica.

David serves as chair and director of the New York eHealth Collaborative overseeing the state’s Health Information Technology initiatives.

Connect With Us

Want to get in touch? We’d love to hear from you.
Avalon Logo

Enjoy our updated website!